High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women

被引:56
|
作者
Ravn, P
Rix, M
Andreassen, H
Clemmesen, B
Bidstrup, M
Gunnes, M
机构
[1] ROSKILDE CTY HOSP KOGE,DEPT INTERNAL MED,ROSKILDE,DENMARK
[2] CTR CLIN OSTEOPOROSIS RES,HAUGESUND,NORWAY
关键词
tiludronate; postmenopausal osteoporosis; urinary CrossLaps; osteocalcin; bone mineral density; spinal fracture; osteoporosis;
D O I
10.1007/s002239900225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A group of 366 healthy, white postmenopausal women, aged 50-81 years, mean age 66 years, were selected from the screened population of Scandinavians who were part of a multicenter study of the efficacy of tiludronate, a new bisphosphonate, in established postmenopausal osteoporosis, Eighty-eight women had a lumbar spine bone mineral density (BMD) above 0.860 g/cm(2), and 278 women had a BMD below 0.860 g/cm2. Spinal fracture was diagnosed from lateral spine X-ray studies and defined as at least 20% height reduction (wedge, compression, or endplate fracture) in at least one vertebra (T4-L4), Bone resorption was assessed by measurement of the urinary excretion of type I collagen degradation products by the CrossLapsTM enzyme-linked immunoassay (ELISA). Bone formation was assessed by ELISA measurement of the N-terminal-midfragment as well as the intact serum osteocalcin (OCN-MID), thus omitting the influence of the instability of osteocalcin caused by the labile 6 amino acid C-terminal sequence. The women were divided into groups with high or low bone turnover according to the concentrations of urinary CrossLapsTM or OCN-MID. Women in the quartiles with the highest concentrations of CrossLaps [519 +/- 119 mu g/mmol (SD)] or OCN-MID [44.6 +/- 7.5 ng/ml (SD)] had 10-16% lower spinal BMD compared with women in the lowest quartiles (CrossLaps 170 +/- 48 mu g/mmol (SD), and OCN-MID [22.1 +/- 3.0 ng/ml (SD)] (P < 0.0004). The prevalences of spinal fracture were 25 to 29% in the lowest quartiles, whereas the prevalences in the highest quartiles were almost double-53-54% (P < 0.006). If the women were subgrouped according to spinal BMD and prevalence of spinal fracture, corresponding results were found. Women with a BMD less than 0.860 g/cm(2), without or with spinal fracture (n = 136 and n = 142), had 36-43% higher concentration of CrossLaps (P = 0.0001) and 11-15% higher concentration of OCN-MID (P < 0.02), as compared with women with a BMD above 0.860 g/cm(2) and no spinal fracture (n = 84). In conclusion, the results indicate a strong association among high bone turnover, low bone mass, and prevalence of spinal fracture, which supports the theory that high bone turnover is a risk factor for spinal fracture and osteoporosis.
引用
收藏
页码:255 / 260
页数:6
相关论文
共 50 条
  • [21] Bone mass and bone turnover in postmenopausal women treated with inhaled glucocorticoids for asthma.
    Taxel, P
    Apter, A
    Kennedy, D
    Willard, A
    Fall, P
    Raisz, LG
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S439 - S439
  • [22] The role of markers of bone turnover in the assessment of fracture risk in postmenopausal women
    Delmas, PD
    OSTEOPOROSIS INTERNATIONAL, 1998, 8 : S32 - S36
  • [23] Influence of Obesity on Bone Turnover Markers and Fracture Risk in Postmenopausal Women
    Lopez-Gomez, Juan J.
    Perez-Castrillon, Jose L.
    de Santos, Isabel Garcia
    Perez-Alonso, Maria
    Izaola-Jauregui, Olatz
    Primo-Martin, David
    De Luis-Roman, Daniel A.
    NUTRIENTS, 2022, 14 (08)
  • [24] Blood homocysteine is correlated with bone mass and bone turnover rate, not with bone size in postmenopausal women.
    Kim, B
    Ahn, B
    Son, J
    Choi, H
    Kim, K
    Kim, S
    Lee, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S275 - S275
  • [25] The gut microbiome is associated with bone turnover markers in postmenopausal women
    Chen, Lin
    Yan, Shuai
    Yang, Ming
    Yu, Fudong
    Wang, Jingjing
    Wang, Xiaoxin
    Xu, Huanbai
    Shi, Jianxia
    Pan, Ling
    Zeng, Yuexi
    Li, Siyu
    Li, Li
    You, Li
    Peng, Yongde
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (11): : 12601 - 12613
  • [26] Bone Metabolism in Postmenopausal Women With Lumbar Spinal Stenosis Analysis of Bone Mineral Density and Bone Turnover Markers
    Kim, Ho-Joong
    Lee, Hwan-Mo
    Kim, Hak-Sun
    Park, Jin-Oh
    Moon, Eun-Su
    Park, Hoon
    Park, Si-Young
    Moon, Seong-Hwan
    SPINE, 2008, 33 (22) : 2435 - 2439
  • [27] Can high bone turnover markers identify osteopenic postmenopausal women at risk of future fracture?
    David M Reid
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 570 - 571
  • [28] Can high bone turnover markers identify osteopenic postmenopausal women at risk of future fracture?
    Reid, David M.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (08): : 570 - 571
  • [29] Vitamin D status is not associated with bone mineral density, bone turnover, bone loss and fracture risk in postmenopausal women. The OFELY study
    Garnero, P.
    Munoz, F.
    Sornay-Rendu, E.
    Delmas, P. D.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S22 - S22
  • [30] Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass
    Recker, Robert R.
    Kendler, David
    Recknor, Christopher P.
    Rooney, Theodore W.
    Lewiecki, E. Michael
    Utian, Wulf H.
    Cauley, Jane A.
    Lorraine, Joanne
    Qu, Yongming
    Kulkarni, Pandurang M.
    Gaich, Carol L.
    Wong, Mayme
    Plouffe, Leo, Jr.
    Stock, John L.
    BONE, 2007, 40 (04) : 843 - 851